Vaxxinity stock holds at USD 0.00 amid thin market data

Vaxxinity stock, tied to Vaxxinity, Inc. (ISIN US92239B1035), was quoted at USD 0.00 on Nasdaq on September 22, 2026, according to the available market snapshot. The same snapshot showed market capitalization of USD 0.00, making the displayed quote the central measurable market figure for the session.

Market data show a zero quote

The September 22, 2026 market display also recorded a previous close of USD 0.00 and a 52-week range of USD 0.00 to USD 0.00. The comparison between the current quote and the prior close was therefore USD 0.00 versus USD 0.00, or 0.00 percent.

That data pattern does not establish an operating valuation or a clinical outcome. It describes the quotation shown for the security and should be separated from the company's research pipeline and financial reporting.

Clinical progress remains the operating lens

Vaxxinity is a biotechnology company developing treatments based on antibodies directed against disease-related proteins. Its investment case is therefore tied to clinical development, regulatory milestones and financing capacity rather than to a mature revenue stream.

For investors, the key distinction is numerical: the displayed market capitalization was USD 0.00 on September 22, 2026, while the latest displayed quote and previous close were also USD 0.00. Those three dated market values provide a snapshot, not a forecast of future clinical or commercial performance.

Nasdaq quote remains at USD 0.00

Vaxxinity stock stood at USD 0.00 on Nasdaq as of September 22, 2026. The fact box records the same venue, currency and date for the reference quote.

More news and analyses on Vaxxinity stock